INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland
Authors:
- 1 March 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 35 (2) , e41-e43
Abstract
Integrase interactor 1 (INI1) is a tumor suppressor gene that is ubiquitously expressed in all nucleated cells. The loss of INI1 protein activity was first demonstrated in aggressive pediatric tumors, including atypical teratoid/rhabdoid (AT/RT) tumor of the central nervous system and malignant rhabdoid tumor of the kidney. Subsequently, INI1 deficiency was discovered in other pediatric and some adult neoplasms. The spectrum of INI1-negative tumors includes a wide variety of neoplasms that occur over a wide age range, are variably aggressive, and have a variable rhabdoid component on histopathologic evaluation. In this report, the authors describe a 27-year-old gravid woman with INI1-deficient carcinoma of the lacrimal gland, previously not described in this location.Keywords
This publication has 12 references indexed in Scilit:
- Oncogenic roles of SMARCB1/INI1 and its deficient tumorsCancer Science, 2017
- The Expanding Family of SMARCB1(INI1)-deficient NeoplasiaAdvances in Anatomic Pathology, 2014
- SMARCB1 (INI1)-negative Rhabdoid Carcinomas of the Gastrointestinal TractAmerican Journal of Surgical Pathology, 2014
- INI1-Deficient TumorsAmerican Journal of Surgical Pathology, 2011
- A Case of Congenital Orbital Malignant Rhabdoid Tumor: Systemic Metastasis following ExenterationOphthalmologica, 2009
- Treatment of unresectable malignant rhabdoid tumor of the orbit with tandem high‐dose chemotherapy and gamma‐knife radiosurgeryPediatric Blood & Cancer, 2006
- Malignant Rhabdoid Tumor of the OrbitArchives of Ophthalmology (1950), 1998
- Adult Extrarenal Rhabdoid Tumor of the Lacrimal GlandOphthalmology, 1992
- Intraorbital rhabdoid tumour following bilateral retinoblastomaHistopathology, 1992
- Malignant Rhabdoid Tumor of the OrbitOphthalmology, 1989